Glenmark Pharmaceuticals Faces Financial Hit Amid US Litigation Settlement
Published on: Aug. 14, 2025, 7:54 p.m. | Source: Devdiscourse
Glenmark Pharmaceuticals Ltd experienced an 86% decline in profit, affected by a US litigation settlement provision. Despite robust growth in its US business and European markets, the financial hit was due to legal expenses regarding antitrust and consumer protection lawsuits. The company emphasizes its commitment to future growth.
